gi

Gilead Sciences

GILD
NASDAQ
$139.71

Does Gilead Sciences have high-quality management?

Gilead Sciences's management shows mixed results. Operational efficiency could be improved, and capital deployment decisions have been inconsistent. The team needs to demonstrate clearer focus on shareholder value creation.